AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 3%
#121 out of 4868 analysts
Average Return
+8.91%
Win Rate
50%166 out of 334
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Cormedix IncCRMD | +230.33% | $3.33 | $11.00 | 2023-11-14 - 2024-11-14 | Buy |
Cormedix IncCRMD | +209.65% | $3.42 | $10.59 | 2024-03-12 - 2025-03-11 | Buy |
Liquidia CorpLQDA | +176.08% | $2.55 | $7.04 | 2021-03-22 - 2022-03-22 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | 11 | Buy | $66.00 | +56.84% | Reiterates | 2 days ago |
Esperion Therapeutics IncESPR | 19 | Buy | $5.00 | +400.50% | Reiterates | 7 days ago |
Heron Therapeutics IncHRTX | 20 | Buy | $4.00 | +65.29% | Reiterates | 21 days ago |
Biocryst Pharmaceuticals IncBCRX | 12 | Buy | $15.00 | +69.49% | Reiterates | 22 days ago |
Liquidia CorpLQDA | 27 | Buy | $25.00 | +78.95% | Reiterates | 22 days ago |
Collegium Pharmaceutical IncCOLL | 21 | Buy | $46.00 | +70.40% | Reiterates | 23 days ago |
Arcutis Biotherapeutics IncARQT | 20 | Buy | $20.00 | +34.14% | Reiterates | 23 days ago |
Evolus IncEOLS | 14 | Buy | $22.00 | +92.98% | Reiterates | 23 days ago |
Cormedix IncCRMD | 16 | Buy | $12.00 | +30.58% | Reiterates | 23 days ago |
Clearside Biomedical IncCLSD | 14 | Buy | $4.00 | +362.43% | Reiterates | 24 days ago |
Newamsterdam Pharma Co NvNAMS | 7 | Buy | $42.00 | +119.55% | Reiterates | 24 days ago |
Pacira Biosciences IncPCRX | 26 | Buy | $32.00 | +18.96% | Reiterates | 24 days ago |
Trevi Therapeutics IncTRVI | 18 | Buy | $24.00 | +247.32% | Reiterates | 24 days ago |
Cytokinetics IncCYTK | 21 | Buy | $72.00 | +68.07% | Reiterates | 24 days ago |
Kalvista Pharmaceuticals IncKALV | 18 | Buy | $28.00 | +103.34% | Reiterates | 24 days ago |
Ocular Therapeutix IncOCUL | 2 | Buy | $15.00 | +80.72% | Reiterates | 24 days ago |
Viridian Therapeutics IncVRDN | 15 | Buy | $38.00 | +180.44% | Reiterates | 4 months ago |
Xenon Pharmaceuticals IncXENE | 11 | Buy | $60.00 | +57.07% | Reiterates | 6 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $12.00 | +2,486.21% | Downgrades | 7 months ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | +228.77% | Reiterates | 9 months ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 2 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Flexion Therapeutics IncFLXN | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.